Followers | 126 |
Posts | 5419 |
Boards Moderated | 0 |
Alias Born | 06/09/2020 |
![](https://investorshub.advfn.com/uicon/747853.png?cb=1644300972)
Sunday, May 12, 2024 4:10:12 AM
That Q&A would've destroyed the most frequently used fud narratives since then, which we've been wasting thousands of posts and hours going in circles around.
For one of the most hardcore fudders it was his Waterloo, leading to a puzzle of a retreat, when littering the Nature article in the comments section with ...
...as there can be wide confusion in this namespace I think it would be proper to update (or note) the formal name of the ATL-DC agent used
Poor thing. Yes, it definitely lead to confusion in this socalled namespace of his, the fud habitat. How would they now be able to continue the two years of having successfully pleaded ignorance on this subject, in which no other namespaces have enjoyed said confusion?
... leading to next in line of controversial topics Linda Liau talked about, combo trial with poly-iclc and a very interesting comment from her.
"When approved poly-iclc can be added off label".
I bet there is some confusion in a certain safespace regarding that.
Here's also an interesting comment from Peter Davis on that.
#dcvax $nwbo #gbm
— Peter Davis (@peter_brit) May 9, 2024
Excellent post by Chiugray
TiltMyBrain, DCVax is about to give a knockout 1-2 punch against brain tumors and will mark a historic moment to the joy of cancer patients and oncologists.
1. Regulatory approvals (first UK, then globally) DCVax-L for stage 4… pic.twitter.com/82pcsTkwB3
Will we ever see DCVax-L be used alone, when approved?
What would be the point?
Are Linda Liau correct?
If yes, it would be a ball buster, a big one ... and no wonder some threatened Al over that one.
![Bullish](/static/images/ih2-bull.png)
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM